Transcriptional abnormalities in Huntington disease

This publication has 39 references indexed in Scilit:

• Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
  Nature, 2003
• Modulation of polyglutamine-induced cell death by genes identified by expression profiling
  Human Molecular Genetics, 2002
• Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
  Human Molecular Genetics, 2002
• Huntingtin Is Present in the Nucleus, Interacts with the Transcriptional Corepressor C-terminal Binding Protein, and Represses Transcription
  Journal of Biological Chemistry, 2002
• Mutant protein in Huntington disease is resistant to proteolysis in affected brain
  Nature Genetics, 2001
• Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease
  Human Molecular Genetics, 2001
• The molecular biology of Huntington's disease
  Psychological Medicine, 2001
• Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
  Nature Genetics, 1998
• Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
  Science, 1997
• Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases.
  Proceedings of the National Academy of Sciences, 1995